Johnson & Johnson vs 3M Company
JNJ vs MMM — side-by-side comparison from reported financials. JNJ leads 7, MMM leads 4 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
3M Company
MMM · Healthcare
$160.20-2.07%Mixed
| Metric | JNJ | MMM |
|---|---|---|
| Price | $261.79 | $160.20 |
| Market cap | $631B | $82.6B |
| Revenue (TTM) | $97.9B | $25.2B |
| Revenue growth | +5.6% | -1.6% |
| Net margin | 21.5% | 11.9% |
| Free cash flow | $22.2B | $3.98B |
| Net cash (debt) | ($27.8B) | ($4.67B) |
| 1-year price return | +37.0% | +4.8% |
| P/E | 29.9 | 27.5 |
| P/E vs own history (cheap-side %) | 16% | 18% |
| Dividend yield | 2.00% | 1.93% |
| Return on equity | 26% | 77% |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 140,800 | 60,500 |
Full résumé-style profiles: JNJ CV · MMM CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.